GENEVA, April 1 -- LANTERN PHARMA INC. (1920 McKinney Avenue, 7th FloorDallas, TX 75201) filed a patent application (PCT/US2024/047149) for "LYOPHILIZED HYDROXYUREAMETHYL ACYLFULVENE" on Sep 18, 2024. With publication no. WO/2025/064461, the details related to the patent application was published on Mar 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KOCHAT, Harry (1920 McKinney Avenue, 7th FloorDallas, TX 75201)
Abstract:
Lyophilized preparations include illudins, including hydroxyureamethyl acylfulvene, and pharmaceutically acceptable salts thereof, in combination with cyclodextrins...